These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11739705)

  • 21. A Virion-Based Assay for Glycoprotein Thermostability Reveals Key Determinants of Filovirus Entry and Its Inhibition.
    Bortz RH; Wong AC; Grodus MG; Recht HS; Pulanco MC; Lasso G; Anthony SJ; Mittler E; Jangra RK; Chandran K
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional importance of the coiled-coil of the Ebola virus glycoprotein.
    Watanabe S; Takada A; Watanabe T; Ito H; Kida H; Kawaoka Y
    J Virol; 2000 Nov; 74(21):10194-201. PubMed ID: 11024148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release of viral glycoproteins during Ebola virus infection.
    Volchkov VE; Volchkova VA; Slenczka W; Klenk HD; Feldmann H
    Virology; 1998 May; 245(1):110-9. PubMed ID: 9614872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.
    Yang ZY; Duckers HJ; Sullivan NJ; Sanchez A; Nabel EG; Nabel GJ
    Nat Med; 2000 Aug; 6(8):886-9. PubMed ID: 10932225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.
    Kaletsky RL; Simmons G; Bates P
    J Virol; 2007 Dec; 81(24):13378-84. PubMed ID: 17928356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.
    Yonezawa A; Cavrois M; Greene WC
    J Virol; 2005 Jan; 79(2):918-26. PubMed ID: 15613320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic understanding of
    Wang B; Wang Y; Frabutt DA; Zhang X; Yao X; Hu D; Zhang Z; Liu C; Zheng S; Xiang SH; Zheng YH
    J Biol Chem; 2017 Apr; 292(14):5860-5870. PubMed ID: 28196864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
    Mittler E; Alkutkar T; Jangra RK; Chandran K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human MARCH1, 2, and 8 block Ebola virus envelope glycoprotein cleavage via targeting furin P domain.
    Yu C; Bai Y; Tan W; Bai Y; Li X; Zhou Y; Zhai J; Xue M; Tang YD; Zheng C; Liu Q
    J Med Virol; 2024 Feb; 96(2):e29445. PubMed ID: 38299743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner.
    Nanbo A; Imai M; Watanabe S; Noda T; Takahashi K; Neumann G; Halfmann P; Kawaoka Y
    PLoS Pathog; 2010 Sep; 6(9):e1001121. PubMed ID: 20886108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth-Adaptive Mutations in the Ebola Virus Makona Glycoprotein Alter Different Steps in the Virus Entry Pathway.
    Ruedas JB; Arnold CE; Palacios G; Connor JH
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ebola sGP--the first viral glycoprotein shown to be C-mannosylated.
    Falzarano D; Krokhin O; Van Domselaar G; Wolf K; Seebach J; Schnittler HJ; Feldmann H
    Virology; 2007 Nov; 368(1):83-90. PubMed ID: 17659315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.
    Watanabe S; Watanabe T; Noda T; Takada A; Feldmann H; Jasenosky LD; Kawaoka Y
    J Virol; 2004 Jan; 78(2):999-1005. PubMed ID: 14694131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and characterization of two GP-specific monoclonal antibodies, which synergistically protect non-human primates against Ebola lethal infection.
    Shcheblyakov D; Esmagambetov I; Simakin P; Kostina L; Kozlov A; Tsibezov V; Grebennikova T; Chifanov D; Rumyantseva I; Boyarskaya N; Sizikova T; Shagarova N; Andrus А; Shatohina I; Syromyatnikova S; Kovalchuk A; Pantyukhov V; Borisevich S; Zubkova O; Tukhvatulin A; Logunov D; Naroditsky B; Gintsburg A
    Antiviral Res; 2019 Dec; 172():104617. PubMed ID: 31593751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperation of the Ebola Virus Proteins VP40 and GP
    Rizk MG; Basler CF; Guatelli J
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry.
    Wang J; Manicassamy B; Caffrey M; Rong L
    Virol Sin; 2011 Jun; 26(3):156-70. PubMed ID: 21667336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.
    Volchkova VA; Dolnik O; Martinez MJ; Reynard O; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S941-6. PubMed ID: 21987773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity.
    Wong G; He S; Leung A; Cao W; Bi Y; Zhang Z; Zhu W; Wang L; Zhao Y; Cheng K; Liu D; Liu W; Kobasa D; Gao GF; Qiu X
    J Virol; 2019 Jan; 93(1):. PubMed ID: 30333174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.